Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement") is made and entered into this 28th day of October, 1999, by and between Innapharma, Inc., a Delaware corporation (the "Company"), and MARTIN F. SCHACKER ("Executive"), a...Employment Agreement • August 14th, 2006 • Tetragenex Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 14th, 2006 Company Industry Jurisdiction
AGREEMENT ---------Patent Security Agreement • June 13th, 2006 • Tetragenex Pharmaceuticals, Inc. • New York
Contract Type FiledJune 13th, 2006 Company Jurisdiction
Exhibit 10.1 SCIENTIFIC CONSULTING AGREEMENTScientific Consulting Agreement • May 31st, 2007 • Tetragenex Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledMay 31st, 2007 Company Industry Jurisdiction
RIDER ATTACHED TO AND FORMING PART OF LEASE DATED , 2008 BY AND BETWEEN GOODRICH EXECUTIVE L.L.C., AS LANDLORD AND TETRAGENEX PHARMACEUTICALS, INC., AS TENANTTetragenex Pharmaceuticals, Inc. • November 14th, 2008 • Pharmaceutical preparations • New Jersey
Company FiledNovember 14th, 2008 Industry Jurisdiction
TETRAGENEX PHARMACEUTICALS, INC. Warrant for the Purchase of Shares of Common StockTetragenex Pharmaceuticals, Inc. • August 13th, 2009 • Pharmaceutical preparations
Company FiledAugust 13th, 2009 IndustryFor value received, this warrant (the “Warrant”) is hereby issued by Tetragenex Pharmaceuticals, Inc., a Delaware corporation (the “Company”), to [ _ ] (the “Holder”). Subject to the provisions of this Warrant, the Company hereby grants to the Holder the right to purchase [ _ ] (___) fully paid and non-assessable shares of the Company’s Common Stock, at the lower of (i) $0.40, or (ii) the price at which any warrants are exercisable in the Company’s next equity financing which results in proceeds to the Company equal to or greater than $100,000 (the “Exercise Price”).
SECURED PROMISSORY NOTETetragenex Pharmaceuticals, Inc. • June 13th, 2006
Company FiledJune 13th, 2006